From: Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis
Cases (n = 83) | Controls (n = 110) | |
---|---|---|
Gendera | ||
Male | 68 (81.9%) | 62 (56.4%) |
Female | 15 (18.1%) | 48 (43.6%) |
Ageb | ||
Median | 69 | 61 |
Range | 42–88 | 24–88 |
Smoking statusc | ||
Yes | 74 (89.2%) | 62 (66%) |
No | 9 (10.8%) | 32 (33%) |
Diagnosis | ||
Healthy | 35 | |
Benign Pathology | 75 | |
RI | 53 (70.7%) | |
ILD | 17 (22.6%) | |
Nodule | 4 (5.3%) | |
ICC | 1 (1.3%) | |
NSCLC Histology | ||
ADC | 40 (48.2%) | |
SCC | 26 (31.3%) | |
LCC | 14 (16.9%) | |
BAC | 2 (2.4%) | |
ND | 1 (1.2%) | |
NSCLC Stage | ||
I | 18 (21.7%) | |
II | 6 (7.2%) | |
III | 22 (26.5%) | |
IV | 37 (44.6%) |